Declaration of Helsinki (DOH) Ethical Guidelines

Overview of the Declaration of Helsinki (DOH)

  • Definition and Scope:
    • The Declaration of Helsinki (DOH) is a set of ethical guidelines specifically established for doctors and researchers to follow when conducting medical research that involves human participants.
    • It was developed and is maintained by the World Medical Association (WMA).
    • The primary goal is to protect the fundamental rights, safety, and overall well-being of individuals participating in clinical research.

Fundamental Principles of Ethical Medical Research

  • Respect for People:
    • All participants must be treated with dignity and respect throughout the duration of the study.
    • The rights and privacy of every participant must be prioritized and protected at all times.
  • Informed Consent:
    • Full Disclosure: Participants must be provided with complete and transparent information regarding the nature, purpose, and details of the study.
    • Voluntary Participation: Potential subjects should agree to participate voluntarily, entirely free from any form of pressure or coercion.
  • Safety First:
    • The health and safety of human participants are inherently more important than the pursuit of research goals or scientific advancement.
    • Researchers must ensure that all potential risks are minimized to the greatest extent possible.
  • Scientific Value:
    • Research must be grounded in established scientific knowledge and possess a clear, useful purpose.
  • Ethics Committee Approval:
    • Before any study begins, it must be reviewed and approved by an independent ethics committee to ensure it meets ethical standards.
  • Confidentiality:
    • All personal information and medical data concerning the participants must be kept strictly private.
  • Publication and Transparency:
    • Researchers are obligated to report their results honestly and accurately, regardless of whether the outcomes are positive or negative.
    • Methodologies should be disclosed openly to ensure transparency and honesty.

History and Origin of the Declaration

  • Pre-Declaration Context:
    • During World War II (WWII), many unethical medical experiments were performed on individuals without their consent.
    • After the war, the Nuremberg trials exposed these horrific experiments to the global community.
    • In 1947, the Nuremberg Code was created as the first major international effort to protect human subjects in research.
  • Formal Creation:
    • The World Medical Association (WMA) established the Declaration of Helsinki in 1964.
    • The document was finalized in Helsinki, Finland.
    • Its purpose was to establish authoritative ethical principles for research involving human beings, specifically for the medical community.

Timeline of Revisions and Major Updates

The declaration has undergone several revisions to stay current with advancements in medicine and research technology:

  • 1975 Tokyo Revision: This version introduced the essential requirement for research to be reviewed by an independent ethical review committee.
  • 1983 Venice Revision: Focused on improving the overall protection of research participants.
  • 1989 Hong Kong Revision: Strengthened the procedures and oversight regarding ethical review.
  • 1196 Somerset West Revision: Added specific guidance regarding the use of placebos in Clinical Trials (CT).
  • 2000 Edinburgh Revision: A major update that significantly increased protections for various types of participants.
  • 2008 Seoul Revision: Clarified rules and regulations specifically regarding clinical trials and the safety of participants.
  • 2013 Fortaleza Revision: This represents the current major version of the Declaration of Helsinki.

Principles for Medical Research Combined with Medical Care

Special guidelines apply when research is integrated with the delivery of medical treatment:

  • Scientific Basis: The research must have a clear scientific foundation, purpose, and demonstrable benefit.
  • Patient Welfare first:
    • The health, safety, and individual rights of the patient must always take precedence over the interests of science or wider society.
  • Benefit to the Patient:
    • A doctor may only combine research with medical care if the research has potential preventive, diagnostic, or therapeutic value for that specific patient.
  • Informed Consent Essentials:
    • Patients must be fully informed of the study's purpose and all procedures involved.
    • They must be appraised of all possible risks and potential benefits.
    • They must understand their absolute right to refuse participation.
  • Freedom to Withdraw:
    • Participants have the right to leave a study at any time. This withdrawal must not affect their access to or the quality of their regular medical treatment.

Protection of Vulnerable Groups

Extra care and specific protections must be implemented when research involves vulnerable populations who may be at higher risk or unable to provide full consent:

  • Children.
  • Elderly people.
  • Pregnant women.
  • Mentally disabled individuals.
  • Economically disadvantaged people.
  • Individuals who are otherwise unable to make decisions for themselves.

Risk Assessment, Conduct, and Post-Trial Obligations

  • Risk-Benefit Assessment: Researchers must carefully weigh and compare all possible risks against the potential benefits before initiating the study.
  • Best Proven Treatment: Whenever possible, patients must receive the current best proven medical treatment. New treatments under study should be compared against the existing best treatment standards.
  • Qualified Researchers: Research must only be conducted by trained, qualified healthcare professionals under strict and proper supervision.
  • Documentation: Researchers are required to maintain accurate records of all observations, procedures, and results recorded during the study.
  • Compensation and Treatment for Harm: If a participant suffers an injury as a result of the research, they must be provided with appropriate medical treatment and financial compensation.
  • Registration of Research: All Clinical Trials (CTs) should be formally registered in a public database.
  • Post-Study Treatment Access: Once a study concludes, participants should be provided with access to the treatments that were identified as beneficial during the research.
  • Safety Monitoring: Participants must be continuously monitored throughout the study. The research must be stopped immediately if serious risks to the participants are discovered.